Competition by inhibitory oligonucleotides prevents binding of CpG to C-terminal TLR9

European Journal of Immunology

Volumn 41, Issue 10, 2011, Pages 2820-2827

  Avalos, Ana M ^a   Ploegh, Hidde L ^a  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

C terminal TLR9; CpG ODN; GpC ODN; Inhibitory oligonucleotide; TLR9

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; OLIGONUCLEOTIDE; TOLL LIKE RECEPTOR 9;

ANIMAL CELL; ARTICLE; BINDING COMPETITION; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

ANIMALS; CPG ISLANDS; DNA, BACTERIAL; LIGANDS; MACROPHAGES; MICE; MICE, INBRED BALB C; OLIGODEOXYRIBONUCLEOTIDES; PROTEIN BINDING; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 9;

EID: 80053145718     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201141563     Document Type: Article

References (31)

1. Krieg, A. M., Yi, A. K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A. et al., CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995. 374: 546-549.
2. Muller, T., Hamm, S. and Bauer, S., TLR9-mediated recognition of DNA. Handb. Exp. Pharmacol. 2008: 183: 51-70.
3. Krieg, A. M., Therapeutic potential of Toll-like receptor 9 activation. Nat. Rev. Drug Discov. 2006. 5: 471-484.
4. Latz, E., Schoenemeyer, A., Visintin, A., Fitzgerald, K. A., Monks, B. G., Knetter, C. F., Lien, E. et al., TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat. Immunol. 2004. 5: 190-198.
5. Rutz, M., Metzger, J., Gellert, T., Luppa, P., Lipford, G. B., Wagner, H. and Bauer, S., Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner. Eur. J. Immunol. 2004. 34: 2541-2550.
6. Kim, Y. M., Brinkmann, M. M., Paquet, M. E. and Ploegh, H. L., UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes. Nature 2008. 452: 234-238.
7. Ewald, S. E., Lee, B. L., Lau, L., Wickliffe, K. E., Shi, G. P., Chapman, H. A. and Barton, G. M., The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor. Nature 2008. 456: 658-662.
8. Park, B., Brinkmann, M. M., Spooner, E., Lee, C. C., Kim, Y. M. and Ploegh, H. L., Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9. Nat. Immunol. 2008. 9: 1407-1414.
9. Sepulveda, F. E., Maschalidi, S., Colisson, R., Heslop, L., Ghirelli, C., Sakka, E., Lennon-Dumenil, A. M. et al., Critical role for asparagine endopeptidase in endocytic Toll-like receptor signaling in dendritic cells. Immunity 2009. 31: 737-748.
10. Krieg, A. M., Wu, T., Weeratna, R., Efler, S. M., Love-Homan, L., Yang, L., Yi, A. K. et al., Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc. Natl. Acad. Sci. USA 1998. 95: 12631-12636.
11. Trieu, A., Roberts, T. L., Dunn, J. A., Sweet, M. J. and Stacey, K. J., DNA motifs suppressing TLR9 responses. Crit. Rev. Immunol. 2006. 26: 527-544.
12. Ashman, R. F., Goeken, J. A., Drahos, J. and Lenert, P., Sequence requirements for oligodeoxyribonucleotide inhibitory activity. Int. Immunol. 2005. 17: 411-420.
13. Klinman, D. M., Zeuner, R., Yamada, H., Gursel, M., Currie, D. and Gursel, I., Regulation of CpG-induced immune activation by suppressive oligodeoxynucleotides. Ann. NY Acad. Sci. 2003. 1002: 112-123.
14. Lenert, P., Stunz, L., Yi, A. K., Krieg, A. M. and Ashman, R. F., CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-kappaB activation. Antisense Nucleic Acid Drug Dev. 2001. 11: 247-256.
15. Peter, M., Bode, K., Lipford, G. B., Eberle, F., Heeg, K. and Dalpke, A. H., Characterization of suppressive oligodeoxynucleotides that inhibit Toll-like receptor-9-mediated activation of innate immunity. Immunology 2008. 123: 118-128.
16. Stunz, L. L., Lenert, P., Peckham, D., Yi, A. K., Haxhinasto, S., Chang, M., Krieg, A. M. et al., Inhibitory oligonucleotides specifically block effects of stimulatory CpG oligonucleotides in B cells. Eur. J. Immunol. 2002. 32: 1212-1222.
17. Lenert, P., Inhibitory oligodeoxynucleotides - therapeutic promise for systemic autoimmune diseases? Clin. Exp. Immunol. 2005. 140: 1-10.
18. Lenert, P. S., Classification, mechanisms of action, and therapeutic applications of inhibitory oligonucleotides for Toll-like receptors (TLR) 7 and 9. Mediators Inflamm. 2010. 2010: 986596.
19. Yamada, H., Gursel, I., Takeshita, F., Conover, J., Ishii, K. J., Gursel, M., Takeshita, S. et al., Effect of suppressive DNA on CpG-induced immune activation. J. Immunol. 2002. 169: 5590-5594.
20. Latz, E., Verma, A., Visintin, A., Gong, M., Sirois, C. M., Klein, D. C., Monks, B. G. et al., Ligand-induced conformational changes allosterically activate Toll-like receptor 9. Nat. Immunol. 2007. 8: 772-779.
21. Lau, C. M., Broughton, C., Tabor, A. S., Akira, S., Flavell, R. A., Mamula, M. J., Christensen, S. R. et al., RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J. Exp. Med. 2005. 202: 1171-1177.
22. +T cells and delays autoimmune diabetes. J. Immunol. 2010. 184: 5645-5653.
23. Cerullo, V., Seiler, M. P., Mane, V., Brunetti-Pierri, N., Clarke, C., Bertin, T. K., Rodgers, J. R. et al., Toll-like receptor 9 triggers an innate immune response to helper-dependent adenoviral vectors. Mol. Ther. 2007. 15: 378-385.
24. Nisbet, A. J. and Billingsley, P. F., A comparative survey of the hydrolytic enzymes of ectoparasitic and free-living mites. Int. J. Parasitol. 2000. 30: 19-27.
25. Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M. et al., A Toll-like receptor recognizes bacterial DNA. Nature 2000. 408: 740-745.
26. Uccellini, M. B., Busconi, L., Green, N. M., Busto, P., Christensen, S. R., Shlomchik, M. J., Marshak-Rothstein, A. et al., Autoreactive B cells discriminate CpG-rich and CpG-poor DNA and this response is modulated by IFN-alpha. J. Immunol. 2008. 181: 5875-5884.
27. Honda, K., Ohba, Y., Yanai, H., Negishi, H., Mizutani, T., Takaoka, A., Taya, C. et al., Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 2005. 434: 1035-1040.
28. Sen, D. and Gilbert, W., Formation of parallel four-stranded complexes by guanine-rich motifs in DNA and its implications for meiosis. Nature 1988. 334: 364-366.
29. Haas, T., Metzger, J., Schmitz, F., Heit, A., Muller, T., Latz, E. and Wagner, H., The DNA sugar backbone 2' deoxyribose determines toll-like receptor 9 activation. Immunity 2008. 28: 315-323.
30. Sester, D. P., Naik, S., Beasley, S. J., Hume, D. A. and Stacey, K. J., Phosphorothioate backbone modification modulates macrophage activation by CpG DNA. J. Immunol. 2000. 165: 4165-4173.
31. Peter, M. E., Kubarenko, A. V., Weber, A. N. and Dalpke, A. H., Identification of an N-terminal recognition site in TLR9 that contributes to CpG-DNA-mediated receptor activation. J. Immunol. 2009. 182: 7690-7697.